Streetbeat News

Equity Actions

SELB

Selecta Biosciences (NASDAQ:SELB) has announced an agreement to transition the manufacturing and development rights and remaining clinical operations of ImmTOR for SEL-212 to its partner, Swedish Orphan Biovitrum AB (Sobi). As of November 6, 2023, Sobi will assume responsibility for the manufacturing and commercial supply of ImmTOR for SEL-212. Selecta believes this transition will streamline its organization and optimize the value of its SEL-212 royalty stream for stockholders. Selecta is eligible to receive up to $615.0 million in remaining regulatory and commercial milestone payments and tiered double-digit royalties on net sales of SEL-212.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:42 pm

XHR

Xenia Hotels & Resorts has updated its full year 2023 outlook, forecasting an adjusted FFO per diluted share of $1.48-$1.55. The guidance reflects macroeconomic uncertainty and does not account for any unanticipated impacts to the business or operations. It also assumes no additional acquisitions, dispositions, equity issuances, or share and/or senior note repurchases. The company expects a negative impact of 250 basis points to Same-Property (32 Hotel) RevPAR Change due to renovation disruption.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:39 pm

PSTV

Plus Therapeutics reported its Q3 financial results and announced a share repurchase program, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:25 pm

PSTV

Plus Therapeutics has announced a share repurchase program to buy back up to $500,000 of its common stock. The move is aimed at returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:20 pm

PAYC

Paycom Software, Inc. (NYSE:PAYC) announced its expansion into Mexico, offering its cloud-based human capital management software, including its employee-guided payroll experience, Beti. This follows Paycom's earlier expansion into Canada and the launch of Global HCM, which made its software available in over 180 countries. The expansion will provide enhanced choices for companies with operations in Mexico.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:15 pm

UNM

Unum Group's Board of Directors has authorized a $500M share repurchase program. This follows the company's current share repurchase program, which expires on December 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:13 pm

RTX

A significant amount of unusual options activity has been detected for Raytheon Technologies Corporation (RTX), with a mix of bullish and bearish stances. The trades have targeted a price range of $75.0 to $100.0 for RTX over the last 3 months. The current price of RTX is up 3.37% at $81.22. Morgan Stanley maintains an Equal-Weight rating on RTX with a price target of $86, while UBS has downgraded its action to Neutral with a price target of $80.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 8:09 pm

LMT

Unusual options activity has been observed for Lockheed Martin (NYSE:LMT), with a bearish stance taken by a large investor. The overall sentiment of these big-money traders is split between 36% bullish and 63% bearish. The price range targeted by these investors over the last 3 months is from $440.0 to $480.0. Morgan Stanley, UBS, JP Morgan, and Citigroup have maintained their ratings on Lockheed Martin with price targets of $510, $470, $481, and $540 respectively.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 8:09 pm

FSLR

First Solar has increased its 2023 EPS guidance from $7.00-$8.00 to $7.20-$8.00.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:03 pm

CBRG

CBRGU

CBRGW

Chain Bridge I (NASDAQ:CBRGU, CBRG, CBRGW) has announced that it will redeem all of its outstanding Class A ordinary shares at a per-share price of approximately $10.80, effective as of the close of business on November 15, 2023. The decision comes as the company will not be able to consummate an initial business combination within the required time period. The company will cease all operations, except those required to wind up the business, and expects that the Nasdaq Stock Market will file a Form 25 with the U.S. Securities and Exchange Commission to delist its securities.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 8:01 pm